Literature DB >> 13850642

Experiences in one hundred thirty-seven patients treated with oral griseofulvin. Special reference to clinical recurrences. the healthy carrier state, and their management.

N J GOLDFARB, M B SULZBERGER.   

Abstract

Entities:  

Keywords:  GRISEOFULVIN/therapy; RINGWORM/therapy

Mesh：

Substances：

Year:  1960        PMID： 13850642     DOI： 10.1001/archderm.1960.03730050215038

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Onychomycosis. Going for cure.

Authors:  A K Gupta; N H Shear
Journal:  Can Fam Physician       Date:  1997-02       Impact factor: 3.275

Review 3.  Clinical and economic factors in the treatment of onychomycosis.

Authors:  T R Einarson; A K Gupta; N H Shear; S Arikian
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

4.  Studies on the treatment of dermatophytic infections of glabrous skin by topical treatment alone or with combination of griseofulvin for comparison.

Authors:  N Erbakan; A N Or; Z Palali; E Basaran
Journal:  Mycopathol Mycol Appl       Date:  1974-04-30

5.  Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.

Authors:  A K Gupta
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

6.  Treatment of superficial fungous infections. Value and limitations of systemic administration of griseofulvin.

Authors:  S AYRES; S AYRES
Journal:  Calif Med       Date:  1961-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.